Spirox LATERA
- Reduced nasal congestion or stuffiness
- Less trouble breathing through the nose
- Improved ability to get enough air through the nose during exercise or exertion
- Reduced nasal blockage or obstruction
- Less trouble sleeping
Patients experienced a reduction in nasal obstruction symptoms of 53.1% at one year. Patients got these results without negative cosmetic effects. Risks included temporary symptoms such as:
- Mild bruising and inflammation
- Awareness of the implant
- Mild pain or irritation
Other risks related to the LATERA™ implant included: discomfort, infection, reaction to material, and device retrieval.
It is thinner than a pin and is about an inch in length.
It strengthens the walls of the nose to resist collapse on inspiration, and that is how Spirox works.
To test whether the Spirox LATERA™ implant might be of benefit, the patient can pull his or her cheek skin where the nose meets the face in the direction of the outside corner of the eye. If that significantly improves breathing, then Spirox LATERA™ might be of benefit.
It can be placed in the outpatient or office setting, with the patient asleep or awake.
It can be of significant benefit in patients seeking revision rhinoplasty because of functional issues resulting from narrowing of their nose.
It has been of benefit in patients who have experienced temporary improvement in breathing from breathe rite strips.
In a few cases, patients could feel the implant after placement. This issue resolved within three weeks of placement.
There is no downtime from work or activity following placement of the implant.
The Spirox LATERA™ implant is covered by most insurance companies and by Medicare.
View the video below to learn more about Spirox LATERA™.
Are you a candidate for Spirox LATERA?
Click on the link below to take a short quiz to determine whether you might be a candidate for Spirox LATERA™ treatment.